Smiths Group (SMIN)
Smiths Group plc operates as a technology company serving the medical technology, security and defense, general industrial, energy, and space and aerospace markets worldwide.
If you are interested in SMIN stock information, you might also be interested in competitors like NasdaqGS:COMM.
With a P/E ratio of 11.04, the stock appears relatively expensive compared to its index ^FTSE at the moment.
The market capitalization of Smiths Group is currently at £5.34 B. This places it among the medium capitalized companies.
The book value reported in the balance sheet results in a P/B ratio of 2.
With one share of Smiths Group investors achieved a dividend of £0.40. This results in a good dividend yield of 2.66%. In the last 16 years, the quarterly dividend has risen constantly.
For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.76. The price of the stock LSE:SMIN is therefore subject to moderate fluctuations in relation to the overall market.
0.22% of SMIN Stocks is owned by insiders.
For Wall Street analysts, a price target of £17.11 is currently considered realistic.
LSE:SMIN has a 52 week range of £13.23 - £16.42 and is currently trading around £14.90.
The low short sale ratio indicated that the value might increase in the foreseeable future.